XenoPort ( XNPT) is a biopharmaceutical company focused on developing and commercializing a portfolio of internally for the treatment of neurological disorders. This stock is trading up 19% to $8.06 in recent trading. Today's Range: $7.08-$8.10 52-Week Range: $3.46-$7.79 Volume: 2 million Three-Month Average Volume: 510,951 >>4 Biotech Stocks Under $10 With Relative Strength From a technical perspective, XNPT is skyrocketing to the upside here with monster volume, and the stock has now entered breakout territory since it's moved above some near-term overhead resistance at $6.70 to $6.76. High-volume breakouts like this are very bullish technical price action. Traders should now look for long-biased traders off any weakness, as long as XNPT can sustain its trend above $6.70 and with strong upside volume flows. I would consider any upside volume day that registers near or above 510,951 shares as bullish. If we continue to see XNPT hold that trend, then this stock has a great chance of re-testing and possibly taking out its next major overhead resistance levels at $11.34 to $11.82. Keep in mind that there's also some past resistance at $7.79 that might be worth keying off of for higher prices.
Cleantech Solutions (CLNT) soared Monday after the metal components manufacturer reported its fourth-quarter results. Revenue increased 29.4% year over year to $22.8 million from $17.6 million mostly due to sales of the company's dyeing and finishing equipment thanks to the demand for Cleantech's low-emission airflow dyeing machines. Net income increased to $2.1 million, or 60 cents per basic and diluted share, from $0.5 million, or 17 cents per basic and diluted share, in the same period one year earlier. Operating expenses decreased 10.7% year over year to $3.1 million from $3.5 million, while operating income increased to $2.8 million from $0.7 million. Operating margin was 12.2% compared to 4.1% in the same period one year earlier. Adjusted EBIDTA rose year over year to $7.3 million from $4.8 million.